Background: The effect of mitomycin-C (MMC) on the reduction of endothelial cell count in
the cornea remains controversial. We aimed to evaluate the effect of MMC on corneal …

Purpose To evaluate short-term changes in central corneal endothelial cell density and
morphology after photorefractive keratectomy (PRK) with mitomycin-C (MMC) 0.02% in …

PURPOSE: To evaluate the effect of mitomycin-C (MMC) on corneal endothelial cells after
laser-assisted subepithelial keratectomy (LASEK). SETTING: Department of Ophthalmology …

ABSTRACT PURPOSE: To evaluate the potential effect of topical mitomycin C (MMC) on the
corneal endothelium of myopic patients undergoing photorefractive keratectomy (PRK) …

AbstractBackground: Mitomycin-C was suggested for application during surface ablation
procedures to reduce post-operative haze formation. It can effectively reduce haze formation …

AIM To study the effect of mitomycin C (MMC) applied during transepithelial photorefractive
keratectomy (TPRK) on the corneal endothelium one week (W1) and three months (M3) after …

PURPOSE: To evaluate the effect of intraoperative use of mitomycin-C (MMC) on the corneal
endothelium during excimer laser photorefractive keratectomy (PRK). SETTING: Vanak Eye …

PURPOSE: To determine whether there is an increased risk to the corneal endothelium
when mitomycin C (MMC) is administered after photorefractive keratectomy (PRK). DESIGN …

PURPOSE: To study the effects of mitomycin-C (MMC) on the corneal endothelium after
surface ablation. METHODS: This prospective observer-masked study comprised 40 …

PURPOSE: To elucidate the distinct role of the intraoperative use of mitomycin C (MMC) on
endothelial cell density after photorefractive keratectomy (PRK) in human eyes. DESIGN …